Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OmniAb (OABI) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for OmniAb (OABI) over the last 5 years, with Q3 2025 value amounting to $28.5 million.

  • OmniAb's Cash & Equivalents rose 477.68% to $28.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 477.68%. This contributed to the annual value of $27.6 million for FY2024, which is 6871.26% up from last year.
  • Per OmniAb's latest filing, its Cash & Equivalents stood at $28.5 million for Q3 2025, which was up 477.68% from $18.3 million recorded in Q2 2025.
  • In the past 5 years, OmniAb's Cash & Equivalents registered a high of $33.4 million during Q4 2022, and its lowest value of $19847.0 during Q3 2022.
  • Over the past 5 years, OmniAb's median Cash & Equivalents value was $19.1 million (recorded in 2024), while the average stood at $15.8 million.
  • Per our database at Business Quant, OmniAb's Cash & Equivalents plummeted by 9452.05% in 2022 and then skyrocketed by 10694388.57% in 2023.
  • Over the past 5 years, OmniAb's Cash & Equivalents (Quarter) stood at $362203.0 in 2021, then soared by 9118.59% to $33.4 million in 2022, then plummeted by 51.01% to $16.4 million in 2023, then soared by 68.71% to $27.6 million in 2024, then rose by 3.4% to $28.5 million in 2025.
  • Its Cash & Equivalents stands at $28.5 million for Q3 2025, versus $18.3 million for Q2 2025 and $10.9 million for Q1 2025.